Huntington's disease is a multi-system disorder

被引:45
|
作者
Mielcarek, Michal [1 ]
机构
[1] Imperial Coll London, Dept Life Sci, London, England
基金
欧洲研究理事会;
关键词
cardiomyopathy; Huntington's disease; neurodegeneration; peripheral tissue pathology; skeletal muscle atrophy; triplet repeat disorder;
D O I
10.1080/21675511.2015.1058464
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Huntington's disease (HD) is one of the most common non-curable rare diseases and is characterized by choreic movements, psychiatric symptoms, and slowly progressive dementia. HD is inherited as an autosomal dominant disorder with complete penetrance. Although brain pathology has become a hallmark of HD, there is a critical mass of new studies suggesting peripheral tissue pathology as an important factor in disease progression. In particular, recently published studies about skeletal muscle malfunction and HD-related cardiomyopathy in HD mouse models strongly suggest their important roles, leading to upcoming preclinical and clinical trials. One might conclude that therapeutic approaches in HD should not be restricted only to the brain pathology but instead major efforts should also be made to understand the cross-talk between diseased tissues like the CNS-Heart or CNS-skeletal muscle axes.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Huntington's disease, calcium, and mitochondria
    Giacomello, Marta
    Hudec, Roman
    Lopreiato, Raffaele
    BIOFACTORS, 2011, 37 (03) : 206 - 218
  • [22] Huntington's disease: A bimolecular vision
    Leite, JF
    REVISTA DE NEUROLOGIA, 2001, 32 (08) : 762 - 767
  • [23] Transgenic models of Huntington's disease
    Sathasivam, K
    Hobbs, C
    Mangiarini, L
    Mahal, A
    Turmaine, M
    Doherty, P
    Davies, SW
    Bates, GP
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 963 - 969
  • [24] Molecular Biology of Huntington's Disease
    Ersoy, Nagehan
    Basak, A. Nazli
    TURKISH JOURNAL OF NEUROLOGY, 2005, 11 (01) : 27 - 44
  • [25] THERAPEUTIC TARGETS FOR HUNTINGTON'S DISEASE
    Sorbera, L. A.
    Dulsat, C.
    Rosa, E.
    DRUGS OF THE FUTURE, 2012, 37 (06) : 437 - 443
  • [26] Huntington’s disease: the coming of age
    Mritunjay Pandey
    Usha Rajamma
    Journal of Genetics, 2018, 97 : 649 - 664
  • [27] Huntington's disease: the coming of age
    Pandey, Mritunjay
    Rajamma, Usha
    JOURNAL OF GENETICS, 2018, 97 (03) : 649 - 664
  • [28] The Huntington's Disease Gene in an Italian Cohort of Patients with Bipolar Disorder
    Ferrari, Camilla
    Capacci, Elena
    Bagnoli, Silvia
    Ingannato, Assunta
    Sorbi, Sandro
    Nacmias, Benedetta
    GENES, 2023, 14 (09)
  • [29] Huntington's disease: Managing neuropsychiatric symptoms in Huntington's disease
    Loi, Samantha M.
    Walterfang, Mark
    Velakoulis, Dennis
    Looi, Jeffrey C. L.
    AUSTRALASIAN PSYCHIATRY, 2018, 26 (04) : 376 - 380
  • [30] Association of obsessive-compulsive disorder and pathological gambling with Huntington's disease in an Italian pedigree: possible association with Huntington's disease mutation
    De Marchi, N
    Morris, M
    Mennella, R
    La Pia, S
    Nestadt, G
    ACTA PSYCHIATRICA SCANDINAVICA, 1998, 97 (01) : 62 - 65